This fact sheet addresses evolving data privacy challenges for pharma, driven by global regulatory shifts like Spain’s AEPD code, Canada’s CPPA, and EFPIA’s 2022 code. Companies must adapt compliance across product lifecycles, from R&D to rebranding, with AI- and ML-enabled workflows reducing administrative burden. IQVIA’s Global Regulatory Affairs team offers strategy, lifecycle management, and operations support, ensuring transparency, faster decisions, and risk mitigation. Services include gap analysis, marketing applications, RIM data maintenance, and submission-ready documents. By aligning technology and expertise, IQVIA helps companies maximize compliance, protect patient data, and sustain revenue potential in complex markets.

Join for free to read